top of page

Quell Therapeutics' CEO describes the process of using genetically modified Tregs for immune dysregulation conditions

  • blonca9
  • Apr 29, 2024
  • 1 min read

Iain McGill discusses the company's clinical stage liver transplant program, as well as the IBD and type 1 diabetes programs that earned Quell a partnership with AstraZeneca.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page